<DOC>
	<DOCNO>NCT00947284</DOCNO>
	<brief_summary>In previous clinical study post-surgical pain investigator find nalbuphine ( Nubain ) , narcotic pain killer , relieve pain effectively combine low-dose naloxone ( Narcan ) , drug use treat narcotic overdose . This find particularly true men . The purpose study find nalbuphine combine naloxone effective relieve experimentally produce pain either drug alone . A second reason study find study medication work effectively woman men . Subjects come University California San Francisco ( UCSF ) Clinical Research Center ( CRC ) 4 study visit . The first visit 2-hour screening ass subject study eligibility . During three visit , investigator use thermal stimulating device produce temporary , non-injurious skin sensitivity subject feel painful . Changes pain measure follow intravenous ( i.v . ) administration study drug . Three drug combination administer , different one visit : 1 ) nalbuphine 5 mg naloxone 0.4 mg , 2 ) naloxone 0.4 mg saline ( inactive solution ) , nalbuphine 5 mg saline . These drug combination administer random order ; subject receive three combination .</brief_summary>
	<brief_title>Effect Nalbuphine Naloxone Experimentally Induced Skin Sensitivity</brief_title>
	<detailed_description />
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Nalbuphine</mesh_term>
	<criteria>Age 18 40 In stable health Speak , read , understand English language If female , must nonlactating pregnant Heat pain detection thresholds 47 ºC/116.6 ºF Inability develop secondary hyperalgesia heat capsaicin stimulation perform screen visit Serious psychiatric psychopathology ( psychotic disorder , substance abuse ) Tattoos area measurement Allergy study drug ( nalbuphine , naloxone , capsaicin ) Current recent use opioids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>